CSBR
CSBR
NASDAQ · Life Sciences Tools & Services

Champions Oncology Inc

$4.67
-0.11 (-2.30%)
Financial Highlights (FY 2026)
Revenue
59.30M
Net Income
-1,171,839
Gross Margin
48.0%
Profit Margin
-2.0%
Rev Growth
+3.3%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 48.0% 48.0% 61.8% 61.8%
Operating Margin -1.9% -1.7% 20.5% 17.5%
Profit Margin -2.0% -1.9% 14.6% 15.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 59.30M 57.39M 19.71M 19.48M
Gross Profit 28.46M 27.55M 12.17M 12.03M
Operating Income -1,138,507 -991,634 4.04M 3.42M
Net Income -1,171,839 -1,020,666 2.89M 3.05M
Gross Margin 48.0% 48.0% 61.8% 61.8%
Operating Margin -1.9% -1.7% 20.5% 17.5%
Profit Margin -2.0% -1.9% 14.6% 15.7%
Rev Growth +3.3% +3.3% +2.4% -6.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 706.7K 706.7K 33.95M 38.63M
Total Equity 32.42M 32.42M 59.74M 52.97M
D/E Ratio 0.02 0.02 0.57 0.73
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 236.0K 217.0K 6.10M 5.64M
Free Cash Flow — — 2.36M 1.92M